Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 8.43% is 16% below its 5-year average of 10.04%, near the low end of its 5-year range (6.96%–15.26%).
As of the fiscal period ended Wednesday, December 31, 2025. 9.55% above its 12-month average of 7.70%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
8.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
7.70%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
8.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
10.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
9.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
9.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
9.69%
CURRENT VS TTM AVG
+9.55%
CURRENT VS 3Y AVG
+2.27%
CURRENT VS 5Y AVG
-16.05%
CURRENT VS 10Y AVG
-11.93%
CURRENT VS 15Y AVG
-7.25%
CURRENT VS 20Y AVG
-13.00%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-1.17%
vs the sector median at left
Quest Diagnostics Incorporated
Market Cap
$26.22B
Return on Invested Capital (ROIC)
8.43%
TTM Avg
7.70%
3Y Avg
8.24%
5Y Avg
10.04%
Market Cap
$26.23B
Return on Invested Capital (ROIC)
7.39%
TTM Avg
6.30%
3Y Avg
5.64%
5Y Avg
7.56%
Market Cap
$25.06B
Return on Invested Capital (ROIC)
13.62%
TTM Avg
14.65%
3Y Avg
16.90%
5Y Avg
17.70%
Market Cap
$24.85B
Return on Invested Capital (ROIC)
20.58%
TTM Avg
10.42%
3Y Avg
9.36%
5Y Avg
7.13%
Market Cap
$28.44B
Return on Invested Capital (ROIC)
5.69%
TTM Avg
6.03%
3Y Avg
3.95%
5Y Avg
3.95%
Market Cap
$23.66B
Return on Invested Capital (ROIC)
-29.70%
TTM Avg
-31.12%
3Y Avg
-12.69%
5Y Avg
0.19%
Market Cap
$23.49B
Return on Invested Capital (ROIC)
-3.14%
TTM Avg
-4.79%
3Y Avg
9.55%
5Y Avg
20.42%
Market Cap
$29.04B
Return on Invested Capital (ROIC)
35.46%
TTM Avg
38.26%
3Y Avg
37.51%
5Y Avg
36.01%
Market Cap
$29.23B
Return on Invested Capital (ROIC)
13.74%
TTM Avg
4.77%
3Y Avg
-7.01%
5Y Avg
-13.46%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated (DGX) | $26.22B | 8.43% | 7.70% | 8.24% | 10.04% |
| Labcorp Holdings Inc. (LH)vs › | $26.23B | 7.39% | 6.30% | 5.64% | 7.56% |
| West Pharmaceutical Services, Inc. (WST)vs › | $25.06B | 13.62% | 14.65% | 16.90% | 17.70% |
| Incyte Corporation (INCY)vs › | $24.85B | 20.58% | 10.42% | 9.36% | 7.13% |
| Medline Inc. (MDLN)vs › | $28.44B | 5.69% | 6.03% | 3.95% | 3.95% |
| Moderna, Inc. (MRNA)vs › | $23.66B | -29.70% | -31.12% | -12.69% | 0.19% |
| BioNTech SE (BNTX)vs › | $23.49B | -3.14% | -4.79% | 9.55% | 20.42% |
| Mettler-Toledo International Inc. (MTD)vs › | $29.04B | 35.46% | 38.26% | 37.51% | 36.01% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $29.23B | 13.74% | 4.77% | -7.01% | -13.46% |
| STERIS plc (STE)vs › | $23.03B | 8.47% | 7.82% | 7.13% | 6.49% |
ROIC
8.4%
ROE
14.1%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 8.43% |
| 2024-12-31 | 6.96% |
| 2023-12-31 | 7.75% |
| 2022-12-31 | 9.83% |
| 2021-12-31 | 15.26% |
| 2020-12-31 | 12.02% |
| 2019-12-31 | 8.10% |
| 2018-12-31 | 8.78% |
| 2017-12-31 | 9.34% |
| 2016-12-31 | 8.47% |
| 2015-12-31 | 10.35% |
| 2014-12-31 | 7.82% |
| 2013-12-31 | 11.56% |
| 2012-12-31 | 9.08% |
| 2011-12-31 | 7.01% |
| 2010-12-31 | 10.83% |
| 2009-12-31 | 11.07% |
| 2008-12-31 | 10.56% |
| 2007-12-31 | 8.90% |
| 2006-12-31 | 14.15% |
| 2005-12-31 | 12.79% |
| 2004-12-31 | 15.24% |
| 2003-12-31 | 12.89% |
| 2002-12-31 | 12.96% |
| 2001-12-31 | 10.01% |
| 2000-12-31 | 7.63% |
| 1999-12-31 | -0.62% |
| 1998-12-31 | 4.27% |
| 1997-12-31 | 6.56% |
| 1996-12-31 | -47.72% |
